Gary Taylor: Got it. Thank you.
Heather Dixon: No problem.
Operator: And our last question will come from Pito Chickering with Deutsche Bank. Please go ahead.
Pito Chickering: Hey, good morning, guys. Nice quarter, and thanks for fitting me in. Two quick questions here. One more follow up on Medicaid redeterminations. As you look at your DSOs tick up slightly sequentially, as redetermination has a bigger impact. Can you just let us know the process for how you learn if a CDC patient has been re-determined? I believe you, bill CDC weekly. So I assume that you know within one or two weeks if that person has been re-determined so that there’s minimal risk of billing gravities that you can’t collect.
Chris Hunter: Yes. Thank you, Pito. I would say it continues to really vary state by state. So there are some states that have proactively worked with us and will actually in the beginning of a period where they’re moving various patients and citizens off of Medicaid, they will share with us proactively when that’s going to happen and who is on the roles. And that enables us to cross reference against our patients and to be much more proactive in reaching out other times that process doesn’t happen. And our patients, even though we have been proactively talking to them about this for some time, will come into us with a hard copy letter that they’ve received where they’ve lost their coverage, and we have to work with them. So we’ve done everything we can to point out the states that have been particularly transparent and shared with others, how that really is in the patient’s best interest, but it really varies state by state.
Pito Chickering: Okay, fair enough. And then a quick modeling question. If you look at OpEx for fourth quarter and take out sorry, OpEx for the third quarter and take out $5.3 million for professional fees per patient day, can we assume a similar number for that for fourth quarter? Just adjusting for that professional liability?
Heather Dixon: I think that’s right. Our other operating expenses have been pretty consistent. Right around 13% of revenue. If you take out the impact of the $5.3 million reserve adjustment, we are at $13.2 for Q3. So we’re right in line with Q3 prior year, which was 13.3%, and then sequentially, Q2 of 2023 was $13.1. So to answer your question, yes, you can expect that that will come right back in line.
Pito Chickering: Great. Thank you so much.
Heather Dixon: No problem.
Operator: And this concludes our question-and-answer session. I’d like to turn the conference back over to Chris Hunter for any closing remarks.
Chris Hunter: Thank you. So before we end the call, I just want to again, thank our committed Facility Leaders, Clinicians and approximately 23,000 dedicated employees across the country who’ve just continued to work tirelessly to meet the needs of patients in a safe and effective manner. We have such a strong foundation and a proven strategy for driving growth in delivering greater value to both the patients we serve and our shareholders. We greatly thank you all for being with us this morning and for your interest in Acadia. And if you all have additional questions today, please don’t hesitate to contact us directly. Have a great day.
Operator: The conference has now concluded. Thank you for attending today’s presentation. You may now disconnect your lines.
